目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Technology
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Blood Screening Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis

Chapter 4. Blood Screening Market: Technology Business Analysis
4.1. Technology Market Share, 2024 & 2030
4.2. Technology Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
4.4. Nucleic Acid Amplification Test (NAT)
4.4.1. Nucleic Acid Amplification Test (NAT) Market, 2018 - 2030 (USD Million)
4.5. ELISA
4.5.1. ELISA Market, 2018 - 2030 (USD Million)
4.6. Chemiluminescence Immunoassay (CLIA & EIA )
4.6.1. Chemiluminescence Immunoassay (CLIA & EIA ) Market, 2018 - 2030 (USD Million)
4.7. Next Generation Sequencing (NGS)
4.7.1. Next Generation Sequencing (NGS) Market, 2018 - 2030 (USD Million)
4.8. Western Blotting (WB)
4.8.1. Western Blotting (WB) Market, 2018 - 2030 (USD Million)

Chapter 5. Blood Screening Market: Product Business Analysis
5.1. Product Market Share, 2024 & 2030
5.2. Product Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.4. Reagent
5.4.1. Reagent Market, 2018 - 2030 (USD Million)
5.5. Instrument
5.5.1. Instrument Market, 2018 - 2030 (USD Million)

Chapter 6. Blood Screening Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamic
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamic
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamic
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamic
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamic
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamic
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamic
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamic
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. Norway
6.5.7.1. Key Country Dynamic
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Norway Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key Country Dynamic
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Denmark Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.9. Sweden
6.5.9.1. Key Country Dynamic
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Sweden Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamic
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamic
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamic
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamic
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. South Korea Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamic
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. Australia Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamic
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamic
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamic
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamic
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamic
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamic
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamic
6.8.5.2. Regulatory Framework
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Abbott
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Danaher Corporation (Beckman Coulter)
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Becton Dickinson and Company
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Bio-Rad Laboratories, Inc.
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Hoffman-La Roche Ltd.
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Grifols, S.A.
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Ortho-Clinical Diagnostics, Inc.
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Siemens Healthcare GmbH
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Thermo Fisher Scientific, Inc.
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. SOFINA s.a (Biomerieux)
7.5.10.1. Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives

List of Tables
Table 1. List Of Secondary Sources
Table 2. List Of Abbreviations
Table 3. Global Blood Screening Market, by Region, 2018-2030 (USD Million)
Table 4. Global Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 5. Global Blood Screening Market, by Product, 2018-2030 (USD Million)
Table 6. North America Blood Screening Market, by Country, 2018-2030 (USD Million)
Table 7. North America Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 8. North America Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 9. U.S. Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 10. U.S. Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 11. Canada Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 12. Canada Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 13. Mexico Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 14. Mexico Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 15. Europe Blood Screening Market, by Country, 2018 - 2030 (USD Million)
Table 16. Europe Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 17. Europe Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 18. UK Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 19. UK Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 20. Germany Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 21. Germany Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 22. France Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 23. France Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 24. Italy Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 25. Italy Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 26. Spain Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 27. Spain Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 28. Norway Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 29. Norway Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 30. Denmark Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 31. Denmark Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 32. Sweden Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 33. Sweden Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 34. Asia Pacific Blood Screening Market, by Country, 2018 - 2030 (USD Million)
Table 35. Asia Pacific Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 36. Asia Pacific Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 37. Japan Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 38. Japan Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 39. China Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 40. China Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 41. India Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 42. India Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 43. Australia Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 44. Australia Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 45. South Korea Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 46. South Korea Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 47. Thailand Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 48. Thailand Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 49. Latin America Blood Screening Market, by Country, 2018 - 2030 (USD Million)
Table 50. Latin America Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 51. Latin America Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 52. Brazil Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 53. Brazil Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 54. Argentina Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 55. Argentina Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 56. Middle East & Africa Blood Screening Market, by Country, 2018 - 2030 (USD Million)
Table 57. Middle East & Africa Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 58. Middle East & Africa Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 59. South Africa Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 60. South Africa Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 61. Saudi Arabia Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 62. Saudi Arabia Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 63. UAE Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 64. UAE Blood Screening Market, by Product, 2018 - 2030 (USD Million)
Table 65. Kuwait Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
Table 66. Kuwait Blood Screening Market, by Product, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Blood Screening Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Data Triangulation Techniques
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value-Chain-Based Sizing & Forecasting
Fig. 7 Market Formulation & Validation
Fig. 8 Market Snapshot
Fig. 9 Product, and Technology Outlook (USD Million)
Fig. 10 Product, and Technology Outlook
Fig. 11 Competitive Landscape
Fig. 12 Blood Screening Market Dynamics
Fig. 13 Blood Screening Market: Porter’s Five Forces Analysis
Fig. 14 Blood Screening Market: PESTLE Analysis
Fig. 15 Blood Screening Market: Technology Segment Dashboard
Fig. 16 Blood Screening Market: Technology Market Share Analysis, 2024 & 2030
Fig. 17 Nucleic Acid Amplification Test (NAT) Market, 2018 - 2030 (USD Million)
Fig. 18 ELISA Market, 2018 - 2030 (USD Million)
Fig. 19 Chemiluminescence Immunoassay (CLIA & EIA ) Market, 2018 - 2030 (USD Million)
Fig. 20 Next Generation Sequencing (NGS) Market, 2018 - 2030 (USD Million)
Fig. 21 Western Blotting (WB) Market, 2018 - 2030 (USD Million)
Fig. 22 Blood Screening Market: Product Segment Dashboard
Fig. 23 Blood Screening Market: Product Market Share Analysis, 2024 & 2030
Fig. 24 Reagent Market, 2018 - 2030 (USD Million)
Fig. 25 Instrument Market, 2018 - 2030 (USD Million)
Fig. 26 Blood Screening Market Revenue, by Region
Fig. 27 Regional marketplace: Key Takeaways
Fig. 28 Regional marketplace: Key Takeaways
Fig. 29 North America Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 30 U.S. Country Dynamics
Fig. 31 U.S. Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 32 Canada Country Dynamics
Fig. 33 Canada Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 34 Mexico Country Dynamics
Fig. 35 Mexico Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 36 Europe Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 37 UK Country Dynamics
Fig. 38 UK Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 39 Germany Country Dynamics
Fig. 40 Germany Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 41 France Country Dynamics
Fig. 42 France Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 43 Italy Country Dynamics
Fig. 44 Italy Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 45 Spain Country Dynamics
Fig. 46 Spain Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 47 Norway Country Dynamics
Fig. 48 Norway Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 49 Sweden Country Dynamics
Fig. 50 Sweden Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 51 Denmark Country Dynamics
Fig. 52 Denmark Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 54 Japan Country Dynamics
Fig. 55 Japan Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 56 China Country Dynamics
Fig. 57 China Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 58 India Country Dynamics
Fig. 59 India Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 60 Australia Country Dynamics
Fig. 61 Australia Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 62 South Korea Country Dynamics
Fig. 63 South Korea Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 64 Thailand Country Dynamics
Fig. 65 Thailand Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 66 Latin America Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 67 Brazil Country Dynamics
Fig. 68 Brazil Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 69 Argentina Country Dynamics
Fig. 70 Argentina Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 71 MEA Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 72 South Africa Country Dynamics
Fig. 73 South Africa Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 74 Saudi Arabia Country Dynamics
Fig. 75 Saudi Arabia Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 76 UAE Country Dynamics
Fig. 77 UAE Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 78 Kuwait Key Country Dynamics
Fig. 79 Kuwait Blood Screening Market, 2018 - 2030 (USD Million)
Fig. 80 Company Categorization
Fig. 81 Company Market Position Analysis
Fig. 82 Strategic Framework